Efegatran sulfate

CAS No. 126721-07-1

Efegatran sulfate( —— )

Catalog No. M34072 CAS No. 126721-07-1

Efegatran sulfate (LY294468 sulfate) is a potent thrombin inhibitor used in the treatment of thrombotic disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 738 In Stock
5MG 1140 In Stock
10MG 1511 In Stock
25MG 2271 In Stock
50MG 3004 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Efegatran sulfate
  • Note
    Research use only, not for human use.
  • Brief Description
    Efegatran sulfate (LY294468 sulfate) is a potent thrombin inhibitor used in the treatment of thrombotic disorders.
  • Description
    Efegatran sulfate (LY294468 sulfate) is a potent thrombin inhibitor used in the treatment of thrombotic disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Thrombin
  • Recptor
    Thrombin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    126721-07-1
  • Formula Weight
    514.6
  • Molecular Formula
    C21H34N6O7S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(=O)(=O)(O)O.C([C@@H](CC1=CC=CC=C1)NC)(=O)N2[C@H](C(N[C@@H](CCCNC(=N)N)C=O)=O)CCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Dabigatran etexilate...

    A prodrug of BIBR-953, which is a potent nonpeptide thrombin inhibitor with Ki of 4.5 nM.

  • Dabigatran ethyl est...

    Dabigatran ethyl ester hydrochloride is an effective inhibitor of ribosyl dihydronicotinic acid amide dehydrogenase (NQO2) with an IC50 value of 0.8 μM and is a thrombin inhibitor.

  • Ximelagatran

    Ximelagatran, a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.